Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111330034 | 11133003 | 4 | F | 201411 | 20160916 | 20150522 | 20160929 | EXP | DE-INCYTE CORPORATION-2015IN002189 | INCYTE | 77.00 | YR | F | Y | 62.00000 | KG | 20160929 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111330034 | 11133003 | 1 | PS | INCB018424 | RUXOLITINIB | 1 | Oral | 30 MG, QD (15 MG, 2 DF PER DAY) | Y | 202192 | TABLET | ||||||||
| 111330034 | 11133003 | 2 | SS | INCB018424 | RUXOLITINIB | 1 | Oral | 10 MG, QD (5 MG,2 DF PER DAY) | Y | 202192 | TABLET | ||||||||
| 111330034 | 11133003 | 3 | SS | INCB018424 | RUXOLITINIB | 1 | Oral | 20 MG, QD (10 MG, 2 DF PER DAY) | Y | 202192 | TABLET | ||||||||
| 111330034 | 11133003 | 4 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, QD | 118275 | MG | Y | 0 | 75 | MG | QD | ||||
| 111330034 | 11133003 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 100 MG, QD | 0 | 100 | MG | |||||||||
| 111330034 | 11133003 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | |||||||||||
| 111330034 | 11133003 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 111330034 | 11133003 | 8 | C | ESOMEP//ESOMEPRAZOLE | 2 | 40 MG, QD | 0 | 40 | MG | ||||||||||
| 111330034 | 11133003 | 9 | C | ESOMEP//ESOMEPRAZOLE | 2 | Unknown | 0 | ||||||||||||
| 111330034 | 11133003 | 10 | C | ESOMEP//ESOMEPRAZOLE | 2 | Unknown | 0 | QD | |||||||||||
| 111330034 | 11133003 | 11 | C | FOSTER | BECLOMETHASONEFORMOTEROL | 1 | Unknown | 400 UG, QD | 0 | 400 | UG | ||||||||
| 111330034 | 11133003 | 12 | C | FOSTER | BECLOMETHASONEFORMOTEROL | 1 | 0 | QD | |||||||||||
| 111330034 | 11133003 | 13 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 5 UG, QD | 0 | 5 | UG | |||||||||
| 111330034 | 11133003 | 14 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | 0 | |||||||||||
| 111330034 | 11133003 | 15 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | 0 | QD | ||||||||||
| 111330034 | 11133003 | 16 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Unknown | 7.5 MG, QD | 0 | 7.5 | MG | ||||||||
| 111330034 | 11133003 | 17 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Unknown | 7.5 MG, QD | 0 | 7.5 | MG | ||||||||
| 111330034 | 11133003 | 18 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Unknown | 7.5 MG, QD | 0 | 7.5 | MG | QD | |||||||
| 111330034 | 11133003 | 19 | C | TORASEMIDE | TORSEMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | ||||||||
| 111330034 | 11133003 | 20 | C | TORASEMIDE | TORSEMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | ||||||||
| 111330034 | 11133003 | 21 | C | TORASEMIDE | TORSEMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111330034 | 11133003 | 1 | Myelofibrosis |
| 111330034 | 11133003 | 4 | Product used for unknown indication |
| 111330034 | 11133003 | 5 | Product used for unknown indication |
| 111330034 | 11133003 | 6 | Myelofibrosis |
| 111330034 | 11133003 | 8 | Product used for unknown indication |
| 111330034 | 11133003 | 11 | Asthma |
| 111330034 | 11133003 | 13 | Chronic obstructive pulmonary disease |
| 111330034 | 11133003 | 16 | Product used for unknown indication |
| 111330034 | 11133003 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111330034 | 11133003 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111330034 | 11133003 | Escherichia urinary tract infection | |
| 111330034 | 11133003 | Haematoma | |
| 111330034 | 11133003 | Haemoglobin decreased | |
| 111330034 | 11133003 | Red blood cell count decreased | |
| 111330034 | 11133003 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111330034 | 11133003 | 1 | 20141028 | 20141106 | 0 | |
| 111330034 | 11133003 | 2 | 20141204 | 20150108 | 0 | |
| 111330034 | 11133003 | 3 | 20150109 | 0 | ||
| 111330034 | 11133003 | 4 | 20100719 | 20150115 | 0 | |
| 111330034 | 11133003 | 5 | 20121109 | 0 | ||
| 111330034 | 11133003 | 7 | 20121109 | 0 |